X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with Panacea Biotech - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs PANACEA BIOTECH - Comparison Results

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE PANACEA BIOTECH SUVEN LIFE/
PANACEA BIOTECH
 
P/E (TTM) x 16.2 84.6 19.2% View Chart
P/BV x 3.0 1.9 160.3% View Chart
Dividend Yield % 1.2 0.0 -  

Financials

 SUVEN LIFE   PANACEA BIOTECH
EQUITY SHARE DATA
    SUVEN LIFE
Mar-16
PANACEA BIOTECH
Mar-14
SUVEN LIFE/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs339149 227.6%   
Low Rs14482 175.5%   
Sales per share (Unadj.) Rs39.284.1 46.6%  
Earnings per share (Unadj.) Rs7.5-18.3 -40.8%  
Cash flow per share (Unadj.) Rs8.8-6.7 -131.0%  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs49.083.7 58.5%  
Shares outstanding (eoy) m127.2861.25 207.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.21.4 448.2%   
Avg P/E ratio x32.4-6.3 -512.9%  
P/CF ratio (eoy) x27.5-17.2 -159.6%  
Price / Book Value ratio x4.91.4 357.1%  
Dividend payout %26.80-   
Avg Mkt Cap Rs m30,7327,074 434.4%   
No. of employees `0001.02.8 34.7%   
Total wages/salary Rs m4161,449 28.7%   
Avg. sales/employee Rs Th5,236.11,874.1 279.4%   
Avg. wages/employee Rs Th436.5527.0 82.8%   
Avg. net profit/employee Rs Th995.5-407.7 -244.1%   
INCOME DATA
Net Sales Rs m4,9955,154 96.9%  
Other income Rs m194100 193.9%   
Total revenues Rs m5,1895,254 98.8%   
Gross profit Rs m1,233-766 -160.9%  
Depreciation Rs m167711 23.5%   
Interest Rs m541,503 3.6%   
Profit before tax Rs m1,205-2,881 -41.8%   
Minority Interest Rs m011 0.0%   
Prior Period Items Rs m0-6 0.0%   
Extraordinary Inc (Exp) Rs m01,771 0.0%   
Tax Rs m25517 1,517.9%   
Profit after tax Rs m950-1,121 -84.7%  
Gross profit margin %24.7-14.9 -166.0%  
Effective tax rate %21.2-0.6 -3,629.3%   
Net profit margin %19.0-21.8 -87.4%  
BALANCE SHEET DATA
Current assets Rs m4,9863,810 130.9%   
Current liabilities Rs m1,0428,365 12.5%   
Net working cap to sales %79.0-88.4 -89.3%  
Current ratio x4.80.5 1,050.3%  
Inventory Days Days61156 39.2%  
Debtors Days Days3967 58.2%  
Net fixed assets Rs m3,12614,480 21.6%   
Share capital Rs m12761 207.7%   
"Free" reserves Rs m3,717903 411.6%   
Net worth Rs m6,2365,127 121.6%   
Long term debt Rs m4325,832 7.4%   
Total assets Rs m8,07919,433 41.6%  
Interest coverage x23.2-0.9 -2,534.3%   
Debt to equity ratio x0.11.1 6.1%  
Sales to assets ratio x0.60.3 233.1%   
Return on assets %12.42.0 632.6%  
Return on equity %15.2-21.9 -69.6%  
Return on capital %18.93.6 519.1%  
Exports to sales %87.524.5 356.8%   
Imports to sales %12.210.2 120.1%   
Exports (fob) Rs m4,3711,264 345.8%   
Imports (cif) Rs m611525 116.4%   
Fx inflow Rs m4,6661,539 303.2%   
Fx outflow Rs m942942 100.0%   
Net fx Rs m3,724597 623.6%   
CASH FLOW
From Operations Rs m922599 153.9%  
From Investments Rs m-619-438 141.4%  
From Financial Activity Rs m-698-303 230.8%  
Net Cashflow Rs m-396-141 280.0%  

Share Holding

Indian Promoters % 63.4 74.5 85.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.6 -  
FIIs % 0.0 1.3 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 23.6 154.7%  
Shareholders   37,287 10,259 363.5%  
Pledged promoter(s) holding % 0.0 35.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   BIOCON LTD  CADILA HEALTHCARE  AUROBINDO PHARMA  PLETHICO PHARMA  GLENMARK PHARMA  

Compare SUVEN LIFE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Weak Finish to the Week Post Vishal Sikka's Exit as CEO of Infosys(Closing)

Share markets in India witnessed selling pressure, led by slump in shares of Infosys Ltd. after Vishal Sikka resigned as chief executive officer of the country's second-largest software services exporter.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Aug 18, 2017 (Close)

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUVEN LIFE 8-QTR ANALYSIS

COMPARE SUVEN LIFE WITH

MARKET STATS